SILO Pharma Total Liabilities

SILO Pharma (SILO) currently reports a total liabilities of $1.3M as of March 2026. That compares with $700K in the prior-year period — up 89.9% year over year. Use the charts on this page to explore SILO Pharma's total liabilities history and peer comparisons.

SILO Pharma's total liabilities increased from $700K to $1.3M — a 89.9% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

SILO Pharma reported $1.3M in total liabilities as of March 2026. That compares with $700K in the prior-year period — up 89.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $1.3M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for SILO Pharma, and consider following SILO for alerts when major investors trade the stock.

SILO Pharma is classified in the Finance sector. On total liabilities, it currently shows $1.3M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Finance are usually more informative than comparing SILO with unrelated industries.